Study guide
15.2 Observational & Experimental Epidemiological Study Designs
Combined Medical Services Examination UPSC CMS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Logistics & Pattern
1.1 UPSC CMS Examination Overview & Eligibility 1.2 Two-Paper Written Exam Pattern & Negative Marking 1.3 Personality Test, Service Allocation & Career Paths
2 Chapter 2: General Medicine - Cardiology & Respiratory
2.1 Coronary Artery Disease & Acute Myocardial Infarction 2.2 Heart Failure & Cardiac Arrhythmias 2.3 Community-Acquired Pneumonia & Pulmonary Tuberculosis 2.4 COPD, Bronchial Asthma & Pulmonary Embolism
3 Chapter 3: General Medicine - Gastroenterology & Hepatology
3.1 Peptic Ulcer Disease & Upper GI Bleeding 3.2 Liver Cirrhosis & Portal Hypertension 3.3 Acute & Chronic Viral Hepatitis & Pancreatitis 3.4 Inflammatory Bowel Disease & Malabsorption Syndromes
4 Chapter 4: General Medicine - Nephrology & Endocrinology
4.1 Acute Kidney Injury & Chronic Kidney Disease 4.2 Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances 4.3 Diabetes Mellitus: Diagnosis, Complications & Management 4.4 Thyroid Disorders & Adrenal Gland Dysfunction
5 Chapter 5: General Medicine - Neurology, Haematology & Infection
5.1 Cerebrovascular Accidents (Stroke) & Epilepsy 5.2 Approach to Anaemia: Microcytic, Megaloblastic & Haemolytic 5.3 Acute & Chronic Leukaemias and Lymphomas 5.4 Tropical & Endemic Infections: Malaria, Typhoid & Dengue
6 Chapter 6: General Medicine - Emergency Medicine & Toxicology
6.1 Acute Anaphylaxis, Sepsis & Cardiopulmonary Resuscitation 6.2 Organophosphate, Paracetamol & Snakebite Toxicology 6.3 Common Dermatological & Psychiatric Manifestations in Internal Medicine 6.4 Musculoskeletal System & Adult Rheumatology
7 Chapter 7: Paediatrics - Neonatology & Child Growth
7.1 Newborn Care, Neonatal Resuscitation & APGAR Score 7.2 Prematurity, Low Birth Weight & Neonatal Jaundice 7.3 Infant & Child Growth & Developmental Milestones
8 Chapter 8: Paediatrics - Child Health & Nutrition
8.1 Protein-Energy Malnutrition (PEM) & Micronutrient Deficiencies 8.2 Universal Immunization Programme (UIP) & Child Vaccines 8.3 Pediatric Diarrhoea, Dehydration & Respiratory Emergencies 8.4 Birth Defects, Genetic Counseling, Autism & Paediatric Accidents/Poisoning
9 Chapter 9: Surgery - General Surgery, Wounds & Shock
9.1 Wound Healing, Surgical Site Infections & Gas Gangrene 9.2 Pathophysiology of Shock & Perioperative Fluid Therapy 9.3 Acute Abdomen: Appendicitis, Peritonitis & Intestinal Obstruction 9.4 Classification, Resuscitation & Management of Thermal Burns 9.5 Medicolegal & Ethical Issues in Surgery
10 Chapter 10: Surgery - Surgical Specialties I
10.1 Inguinal, Femoral & Ventral Hernias 10.2 Benign Breast Diseases & Breast Carcinoma 10.3 Solitary Thyroid Nodule & Thyroid Carcinoma 10.4 Benign Prostatic Hyperplasia & Renal Calculi
11 Chapter 11: Surgery - ENT, Orthopaedics & Anaesthesia
11.1 Acute Otitis Media, Tonsillitis & Epistaxis 11.2 Cataract, Glaucoma & Red Eye Emergencies 11.3 Principles of Fracture Management & Common Dislocation 11.4 Principles of Local, Regional & General Anaesthesia 11.5 Neurosurgery: Raised ICP, Head Injury & CNS Lesions 11.6 Thoracic Surgery: Chest Trauma, Pleural & Lung Disease
12 Chapter 12: Obstetrics - Antenatal Care & Complications
12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment 12.2 Preeclampsia, Eclampsia & Gestational Hypertension 12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae 12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus 12.5 Spontaneous & Recurrent Abortion: Recognition & Management
13 Chapter 13: Obstetrics & Gynaecology - Labor & PPH
13.1 Normal Labor Mechanisms & Partograph Monitoring 13.2 Malpresentations, Breech & Obstructed Labor 13.3 Postpartum Haemorrhage (PPH) Causes & Management 13.4 Puerperal Sepsis & Postnatal Maternal Care
14 Chapter 14: Gynaecology & Family Planning
14.1 Abnormal Uterine Bleeding & Uterine Fibroids 14.2 Cervical Screening (Pap Smear) & Pelvic Inflammatory Disease 14.3 Temporary & Permanent Contraceptive Methods in India 14.4 Medical Termination of Pregnancy (MTP): Law & Methods
15 Chapter 15: PSM - Epidemiology & Biostatistics
15.1 Principles of Epidemiology & Disease Transmission 15.2 Observational & Experimental Epidemiological Study Designs 15.3 Evaluation of Screening Tests: Sensitivity, Specificity & Predictive Value 15.4 Biostatistics: Sampling, Central Tendency & Significance Testing
16 Chapter 16: PSM - Disease Epidemiology & Programmes
16.1 Epidemiology & Control of TB, Malaria & Dengue 16.2 National Tuberculosis Elimination Programme & NVBDCP 16.3 Epidemiology of Hypertension, Diabetes & Cancer in India 16.4 Cold Chain Management & Vaccine Logistics in India 16.5 Genetics and Health: Inheritance, Screening & Counseling
17 Chapter 17: PSM - Health Planning & Environmental Health
17.1 Demography, Fertility Rates & Family Welfare Indicators 17.2 Safe Water Supply, Waste Disposal & Air Pollution 17.3 Occupational Health Hazards & Pneumoconioses 17.4 Health Care Delivery System, Ayushman Bharat & National Health Mission 17.5 International Health: WHO, Global Agencies & SDG 3 17.6 Medical Sociology & Health Education
15.2 Observational & Experimental Epidemiological Study Designs
Key Takeaways Explain This Topic AI
Case-Control studies proceed from Effect to Cause (Retrospective), are fast, economical, ideal for rare diseases, and yield the Odds Ratio (OR = ad / bc).
Cohort studies proceed from Cause to Effect (Prospective/Retrospective), measure true disease Incidence, Relative Risk (RR), and Attributable Risk (AR).
Overmatching occurs in Case-Control studies when matching is performed on a variable that is closely related to the exposure of interest, destroying the ability to evaluate the exposure.
Randomized Controlled Trials (RCTs) represent the gold standard of evidence; randomization eliminates selection bias and balances both known and unknown confounding variables across arms.
Population Attributable Risk (PAR = [It - Iu] / It) quantifies the proportion of disease incidence in the total population that would be eliminated if the exposure were completely removed.
Last updated: July 2026
Observational & Experimental Epidemiological Study Designs
Epidemiological studies are broadly classified into Observational (where the investigator observes natural exposures without intervention) and Experimental (where the investigator actively manipulates exposure status via randomization). +---------------------------------------------------------------------------------------------------+
- | EPIDEMIOLOGICAL STUDY DESIGNS |
- +---------------------------------------------+-----------------------------------------------------+
- | OBSERVATIONAL STUDIES | EXPERIMENTAL STUDIES |
- +----------------------+----------------------+-----------------------------------------------------+
- | Descriptive | Analytical | Randomized Controlled Trials (RCT) |
- +----------------------+----------------------+-----------------------------------------------------+
- | • Case Report | • Case-Control | • Clinical Trials (Patients) |
- | • Case Series | • Cohort Study | • Field Trials (Healthy Individuals) |
- | • Cross-Sectional | | • Community Trials (Communities/Groups) |
- | • Ecological Study | | |
- +----------------------+----------------------+-----------------------------------------------------+
- 1. Descriptive Studies & Cross-Sectional Design
- Cross-Sectional Study (Prevalence Study)
In a cross-sectional study , exposure status and disease outcome are measured simultaneously in a defined population at a single point in time ("snapshot").
Advantages : Fast, inexpensive, excellent for assessing public health burden and disease prevalence.
Disadvantages : Cannot establish temporal sequence (whether exposure preceded outcome); subject to survivorship bias (selects for cases of long duration).
Key Formula : P = I × D P = I \times D P = I × D (Prevalence = Incidence × \times × Mean Duration of disease).
Ecological Study (Correlational Study)
The unit of observation in an ecological study is a group or population (e.g., countries, states) rather than individual human beings.
Ecological Fallacy : The logical error of inferring that an association observed between variables at the aggregate group level necessarily holds true for individuals within those groups.
2. Case-Control Studies (Trohoc / Retrospective Design)
A Case-Control study begins with diseased individuals ( Cases ) and non-diseased individuals ( Controls ), looking backward in time to compare the frequency of past exposure to potential risk factors. Backward Direction of Inquiry (Effect -> Cause)
- <===================================
- TIME: Past Exposure Present Status
- +-------------------+ +-------------------+
- | Exposed (a) | <------------ | CASES (Disease +) |
- | Unexposed (c) | +-------------------+
- +-------------------+ +-------------------+
- | Exposed (b) | <------------ | CONTROLS (Disease-|
- | Unexposed (d) | +-------------------+
- +-------------------+
- 2x2 Contingency Table for Case-Control Studies
- Exposure Status Cases ( D + D+ D + ) Controls ( D − D- D − ) Total
- Exposed ( E + E+ E + ) a a a (Exposed Case) b b b (Exposed Control) a + b a+b a + b
- Unexposed ( E − E- E − ) c c c (Unexposed Case) d d d (Unexposed Control) c + d c+d c + d
- Total a + c a+c a + c b + d b+d b + d N = a + b + c + d N = a+b+c+d N = a + b + c + d
- Measure of Association: Odds Ratio (OR)
Because case-control studies select participants based on disease status (fixing the number of cases and controls), incidence rates cannot be directly calculated . The measure of association is the Odds Ratio (OR) , also called the Cross-Product Ratio: Odds of exposure among Cases = a c \text{Odds of exposure among Cases} = \frac{a}{c} Odds of exposure among Cases = c a Odds of exposure among Controls = b d \text{Odds of exposure among Controls} = \frac{b}{d} Odds of exposure among Controls = d b Odds Ratio (OR) = a / c b / d = a × d b × c \text{Odds Ratio (OR)} = \frac{a/c}{b/d} = \frac{a \times d}{b \times c} Odds Ratio (OR) = b / d a / c = b × c a × d
Interpretation :
O R = 1.0 OR = 1.0 OR = 1.0 : Exposure is not associated with disease.
O R > 1.0 OR > 1.0 OR > 1.0 : Positive association (Exposure is a potential risk factor).
O R < 1.0 OR < 1.0 OR < 1.0 : Negative association (Exposure is a protective factor).
Matching & Overmatching
Matching : Process of selecting controls so that they are similar to cases in terms of specific confounding variables (e.g., age, sex, social class).
Overmatching : Occurs when matching is performed on variables that are closely tied to the exposure of interest, or when matching is done on intermediate variables in the causal pathway. Overmatching reduces study efficiency and obscures true exposure-disease relationships.
Major Biases in Case-Control Studies
Recall Bias : Cases (having suffered a disease) remember past exposures more vividly or differentially than healthy controls.
Selection Bias : Non-representative selection of cases or controls (e.g., Berkson's Bias / admission rate bias when controls are selected from hospitalized populations).
3. Cohort Studies (Prospective / Follow-Up / Longitudinal Design)
A Cohort study begins with a group of exposed and unexposed disease-free individuals and follows them forward over time to measure and compare the incidence of disease development. Forward Direction of Inquiry (Cause -> Effect)
- ===================================>
- TIME: Present Status Future Outcome
- +-------------------+ +-------------------+
- | EXPOSED GROUP | ------------> | Disease + (a) |
- | (Disease-Free) | | Disease - (b) |
- +-------------------+ +-------------------+
- | UNEXPOSED GROUP | ------------> | Disease + (c) |
- | (Disease-Free) | | Disease - (d) |
- +-------------------+ +-------------------+
- 2x2 Contingency Table for Cohort Studies
- Exposure Status Disease Developed ( D + D+ D + ) Disease Free ( D − D- D − ) Total Group Incidence of Disease
- Exposed ( E + E+ E + ) a a a b b b a + b a+b a + b I e = a a + b I_e = \frac{a}{a+b} I e = a + b a
- Unexposed ( E − E- E − ) c c c d d d c + d c+d c + d I u = c c + d I_u = \frac{c}{c+d} I u = c + d c
- Key Quantitative Metrics in Cohort Studies
Incidence Rates :
- Incidence in Exposed ( I e I_e I e ) = a a + b \frac{a}{a+b} a + b a
- Incidence in Unexposed ( I u I_u I u ) = c c + d \frac{c}{c+d} c + d c
- Total Population Incidence ( I t I_t I t ) = a + c a + b + c + d \frac{a+c}{a+b+c+d} a + b + c + d a + c
Relative Risk (RR) / Risk Ratio : R R = I e I u = a / ( a + b ) c / ( c + d ) RR = \frac{I_e}{I_u} = \frac{a / (a+b)}{c / (c+d)} RR = I u I e = c / ( c + d ) a / ( a + b )
Direct measure of the strength of causal association between exposure and disease.
Attributable Risk (AR) / Etiological Fraction : A R = I e − I u I e × 100 AR = \frac{I_e - I_u}{I_e} \times 100 A R = I e I e − I u × 100
Quantifies the proportion of disease in the exposed population that can be attributed directly to the exposure (and eliminated if exposure is removed).
Population Attributable Risk (PAR) : P A R = I t − I u I t × 100 PAR = \frac{I_t - I_u}{I_t} \times 100 P A R = I t I t − I u × 100
Quantifies the proportion of disease incidence in the entire target population attributable to the risk factor. Crucial for prioritizing public health interventions.
4. Head-to-Head Comparison: Case-Control vs. Cohort Study
Characteristic Case-Control Study Cohort Study
Directionality Retrospective (Effect → \rightarrow → Cause) Prospective or Historical (Cause → \rightarrow → Effect)
Primary Measure Odds Ratio ( O R = a d / b c OR = ad/bc OR = a d / b c ) Relative Risk ( R R = I e / I u RR = I_e / I_u RR = I e / I u ), Incidence
- Rare Diseases Excellent / Ideal design Inefficient (requires massive sample size)
- Rare Exposures Inefficient Excellent / Ideal design
- Multiple Outcomes Examines only 1 outcome per study Examines multiple outcomes from 1 exposure
- Cost & Time Relatively cheap and quick Expensive and time-consuming
- Primary Bias Risk Recall bias, Selection bias Attrition bias (Loss to follow-up)
- Temporal Sequence Hard to establish firmly Firmly establishes temporal precedence
- 5. Experimental Studies & Randomized Controlled Trials (RCT)
An RCT is an experimental design where human participants are randomly assigned to receive an intervention (experimental arm) or standard treatment/placebo (control arm). +---------------------------------------------------------------------------------------------------+
- | STAGES OF A CLASSIC PARALLEL RCT |
- +---------------------------------------------------------------------------------------------------+
- | Target Population ---> Study Sample (Informed Consent) ---> RANDOMIZATION |
- | | |
- | +-------------------------------------------------+---------------------------------+
- | | |
- | v v
- | [ Experimental Group ] [ Control Group ]
- | (Receives New Drug / Intervention) (Receives Placebo / Standard)
- | | |
- | v v
- | Follow-Up Assessment Follow-Up Assessment
- | | |
- | v v
- | Outcome: Improved / Unimproved Outcome: Improved / Unimproved
- +---------------------------------------------------------------------------------------------------+
- Key Methodological Elements of RCTs
Randomization : The central mechanism that allocates subjects to treatment arms purely by chance. Its vital function is to eliminate selection bias and ensure equal, balanced distribution of both known and unknown confounding variables between arms.
Blinding (Masking) :
Single-blind : Subject is unaware of treatment assignment.
Double-blind : Subject and evaluating clinician/investigator are unaware. Eliminates observer/investigator bias.
Triple-blind : Subject, investigator, and biostatistician analyzing data are all unaware.
Crossover Design : Subjects receive Treatment A, undergo a washout period (to eliminate residual pharmacological effect), and then switch to receive Treatment B. Each subject acts as their own control, controlling for inter-individual variability.